![Fred van Leuven](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fred van Leuven
Corporate Officer/Principal bij
Katholieke Universiteit Leuven
Profiel
Fred van Leuven is the founder of AC Immune SA, founded in 2003, and reMYND NV, founded in 2002.
Dr. van Leuven currently holds the position of Professor at Katholieke Universiteit Leuven.
Dr. van Leuven earned a doctorate degree from Ghent University in 1976 and a graduate degree from Ghent University in 1970.
Actieve functies van Fred van Leuven
| Bedrijven | Functie | Begin |
|---|---|---|
Katholieke Universiteit Leuven
 Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Fred van Leuven
| Bedrijven | Functie | Einde |
|---|---|---|
| AC IMMUNE SA | Oprichter | - |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Oprichter | - |
Opleiding van Fred van Leuven
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
53
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Katholieke Universiteit Leuven
Katholieke Universiteit Leuven Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services Engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders | Commercial Services |
